Life Healthcare’s share price fell up to 9% after the group announced a R2.9bn adjustment to the “Piramal liability”, tied to potential earnout payments of up to $400m from the disposal of Life Molecular Imaging. The adjustment cut earnings by about 201c per share, pushing the group into a headline loss of 91.7c–96.4c, compared with last year’s 93.4c profit. Despite this, core operations in Southern Africa remain strong: NEPS is expected to rise 7%–12%, supported by revenue growth, higher patient activity, and strong complementary services. Margin pressure persists, particularly from the renal dialysis business and inflationary cost increases. – Business Day (20 Nov 2025)